President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
How Florida Passed New Gun Laws after Parkland School Shooting
The school shooting in Texas that left 19 children and 2 teachers dead has reignited the debate over gun control. The tragedy in Uvalde is the deadliest school shooting in nearly a decade and marks the latest in a string of mass shootings in the country. Jared Moskowitz, Broward County Commissioner and candidate for Congress in FL-23, joined Cheddar's Opening Bell to discuss why gun control measures are stalled in the Senate, and where legislation can move forward from here.
What Comes Next For Investigators In Uvalde School Shooting
Police and detectives are still investigating the tragic school shooting in Uvalde, Texas that killed 19 children and two adults. Cheddar News was joined by Kirk Burkhalter, professor at New York Law School and former NYPD detective to gain some insight on what investigators are looking for and what comes next.
Robb Elementary School Shooting Is Second-Deadliest in U.S. History
Cheddar News reporter Megan Pratz brings the latest from the scene of yesterday's horrific school shooting at a Robb Elementary School in Uvalde, Texas. Now the second-deadliest school shooting in U.S. history with 19 children and two adults killed, Pratz goes into comments by Texas Gov. Greg Abbott, details about the deceased shooter, and reactions from members of the community.
Security Expert Breaks Down Texas School Shooting Investigation
The Robb Elementary School mass shooting killing 19 children and two adults in Uvalde, Texas pm Tuesday was the deadliest school shooting since the 2012 Sandy Hook massacre in Newtown, Connecticut, and came just 10 days after the grocery store shooting in Buffalo, New York. Nelson Vergara, the founder and CEO of 360 Protective Solutions, joined Cheddar’s Opening Bell to discuss. "Right now what law enforcement is concentrating on is trying to trace his steps as to what motivated the gunman to act the way he did. What it boils down to just trying to figure out what led to his motivation to do such a horrific act.”
Poll Finds Racial Splits on Worries Over COVID-19 Pandemic
An recently conducted AP-NORC poll found that majorities of the Black and Hispanic populations in the U.S. still find themselves either somewhat worried or extremely worried over the pandemic, while more than half of white Americans responded with either being not too worried or not worried at all. Dr. Chris Pernell, the chief strategic integration and health equity officer at University Hospital, joined Cheddar News to talk about how perceptions of COVID-19 differ between groups of Americans. "We’re still seeing people get infected, and because of the toll of the disproportionate impact, we have concerns among the Black and brown community about whether or not they have an increased risk of exposure because of where they work, because of the use of public transportation, because they live in homes that they may not be able to safely quarantine and or isolate in, and because they have at baseline chronic health conditions that may make coronavirus more severe in those persons," she said.
Calif. Probes ExxonMobil Over Accusations of Lying About Plastic Recycling
Judith Enck, a former regional administrator for the EPA and the president of Beyond Plastics, joined Cheddar News to talk about the role of plastics in the climate crisis and California's investigation of ExxonMobil and other oil companies for misleading the public on the ability to recycle plastics. "The reason why petrochemical companies like Exxon have gotten away with selling more and more plastic is that they've lied to the public and told us don't worry about all those negative upstream impacts and downstream impacts of plastics. Just be sure to recycle it. Well, guess what? Plastics largely are not recycled," Enck said.
Load More